Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,241 | 254 | 2,635 | -13,580 | -17,243 |
| Depreciation Amortization | 1,740 | 1,579 | 481 | 1,310 | 818 |
| Accounts receivable | -2,166 | -1,050 | 145 | -18,744 | -6,902 |
| Accounts payable and accrued liabilities | 308 | 328 | 624 | 8,469 | 6,948 |
| Other Working Capital | -22,814 | -26,454 | -14,463 | -27,603 | -9,260 |
| Other Operating Activity | 21,766 | 5,605 | 1,708 | 27,619 | 14,890 |
| Operating Cash Flow | $-18,407 | $-19,738 | $-8,870 | $-22,529 | $-10,749 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,700 | 9,871 | 2,340 | 20,393 | 8,364 |
| PPE Investments | -235 | -264 | -67 | -1,679 | -1,068 |
| Investing Cash Flow | $21,465 | $9,607 | $2,273 | $18,714 | $7,296 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 142,037 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 20,632 | 845 | 64 | 940 | 517 |
| Other Financing Activity | -148,461 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $14,208 | $845 | $64 | $940 | $517 |
| Beginning Cash Position | 25,802 | 25,802 | 25,802 | 28,677 | 28,677 |
| End Cash Position | 43,068 | 16,516 | 19,269 | 25,802 | 25,741 |
| Net Cash Flow | $17,266 | $-9,286 | $-6,533 | $-2,875 | $-2,936 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,407 | -19,738 | -8,870 | -22,529 | -10,749 |
| Capital Expenditure | -317 | -317 | -109 | -1,706 | -1,068 |
| Free Cash Flow | -18,724 | -20,055 | -8,979 | -24,235 | -11,817 |